z-logo
open-access-imgOpen Access
Hsa-miR-30e-3p inhibits influenza B virus replication by targeting viral NA and NP genes
Author(s) -
Kritsada Khongnomnan,
Suthat Saengchoowong,
Oraphan Mayuramart,
Pattaraporn Nimsamer,
Trairak Pisitkun,
Yong Poovorawan,
Sunchai Payungporn
Publication year - 2020
Publication title -
experimental biology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 146
eISSN - 1535-3702
pISSN - 1535-3699
DOI - 10.1177/1535370220953151
Subject(s) - virus , virology , viral replication , biology , influenza a virus , gene , microrna , in silico , orthomyxoviridae , h5n1 genetic structure , genetics , medicine , covid-19 , infectious disease (medical specialty) , disease , pathology
Influenza B virus is a member of the Orthomyxoviridae family which can infect humans and causes influenza. Although it is not pandemic like influenza A virus, it nevertheless affects millions of people worldwide annually. MicroRNAs are small non-coding RNAs regulating gene expression at posttranscriptional level. They play various important roles in cellular processes including response to viral infection. MiRNA profiles from our previous study suggested that miR-30e-3p was one of the upregulated miRNAs that responded to influenza B virus infection. In this study, in silico prediction and in vitro investigation proved that this miRNA can directly target NA and NP genes of the influenza B virus and inhibit its replication. This finding might be useful for using miRNA as an alternative therapeutics for influenza virus infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here